| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/20/2005 | EP1553924A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/20/2005 | EP1553923A1 Camptothecin-carboxylate formulations |
| 07/20/2005 | EP1553910A1 A capsule filling machine |
| 07/20/2005 | EP1553909A2 Quick dissolve compositions and tablets based thereon |
| 07/20/2005 | EP1553904A2 Topical patch preparation kit containing a delayed-type hypersensitivity inducer |
| 07/20/2005 | EP1429748B1 Solid compositions comprising ramipril |
| 07/20/2005 | EP1401467A4 Alpha-fetoprotein peptides and uses thereof |
| 07/20/2005 | EP1345605B1 THERMOFORMed SOLID PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF PERINDOPRIL |
| 07/20/2005 | EP1299348A4 Compounds and compositions for delivering active agents |
| 07/20/2005 | EP1198570B1 Monomeric protein of the tgf-beta family |
| 07/20/2005 | EP1185493B1 Quinones for treatment of diseases |
| 07/20/2005 | EP1001759B1 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 07/20/2005 | EP0871431B1 Hepatocyte-selective oil-in-water emulsion |
| 07/20/2005 | EP0869814B1 Stabilisers for live vaccines |
| 07/20/2005 | EP0759939B1 Methods and compositions for the dry powder formulation of interferons |
| 07/20/2005 | EP0677295B1 Liposome having oligosaccharide on the surface |
| 07/20/2005 | CN1643143A Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 07/20/2005 | CN1642978A Peptides and peptidommetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 07/20/2005 | CN1642952A Micronized crystalline tiotropium bromide |
| 07/20/2005 | CN1642578A Topical composition comprising a cyclofructan, a carrier and a drug |
| 07/20/2005 | CN1642577A Preparation comprising buprenorphine |
| 07/20/2005 | CN1642576A Absorption enhancing agent |
| 07/20/2005 | CN1642575A Test system for evaluating the compatibility of biologically active substances with copolymers |
| 07/20/2005 | CN1642570A Stable pharmaceutical composition containing factor viii |
| 07/20/2005 | CN1642567A HIV inhibiting proteins |
| 07/20/2005 | CN1642566A Chimeric hybrid analgesics |
| 07/20/2005 | CN1642564A Composition containing moutan root bark extract as active ingredient |
| 07/20/2005 | CN1642561A Compositions containing labile bioactive materials, methods of preparation and treatment |
| 07/20/2005 | CN1642549A Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo'1, 5-bipyridazine in nanoparticulate form |
| 07/20/2005 | CN1642546A Solid preparation containing single crystal form |
| 07/20/2005 | CN1642540A Suramin and derivatives thereof as topical microbicide and contraceptive |
| 07/20/2005 | CN1642539A Diclofenac sodium oral pharmaceutical |
| 07/20/2005 | CN1642538A Use of adapalene for the treatment of dermatological disorders |
| 07/20/2005 | CN1642537A Ibuprofen solution for hard shell capsules |
| 07/20/2005 | CN1642534A HFA suspension formulations containing an anticholinergic |
| 07/20/2005 | CN1642532A Sustained release formulation of tramadol |
| 07/20/2005 | CN1642531A Palatable chewable tablet |
| 07/20/2005 | CN1642530A Compressed tablets comprising microcapsules with modified release |
| 07/20/2005 | CN1642529A Matrix for sustained, invariant and independent release of active compounds |
| 07/20/2005 | CN1642528A Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 07/20/2005 | CN1642527A Stabilized natural cannabinoid formulation |
| 07/20/2005 | CN1642526A Formulations of atorvastatin stabilized with alkali metal additions |
| 07/20/2005 | CN1642525A HFA suspension formulations of an anhydrate |
| 07/20/2005 | CN1642503A Therapeutical polyanhydride compounds for drug delivery |
| 07/20/2005 | CN1642415A Palatable oral suspension and method |
| 07/20/2005 | CN1641024A Anti EB virus resulted tumour polypeptide, and its use and preparing method |
| 07/20/2005 | CN1641023A Plasmid of recombinant immunotoxin Rantes-DT390 aimed at activating Th1 cell, and its preparing method and use |
| 07/20/2005 | CN1640496A Recombinant adenovirus lyophilized preparation and its preparing method |
| 07/20/2005 | CN1640495A Ophthalmological anti proliferative medicine containing sodium alginate micro gel bead and convex membrane and preparing method |
| 07/20/2005 | CN1640435A Beta-cyclodextrin and polyoxyethylenated castor oil for preparing injection liquid for restoring conscious ness and its preparing method |
| 07/20/2005 | CN1640412A 西地碘口含片 West to iodine buccal tablets |
| 07/20/2005 | CN1640395A Supermolecular intercalation-structure slow-release captopril and its preparing method |
| 07/20/2005 | CN1640385A Magnetic medicinal microball for directional breaking nerve back root and its preparing method |
| 07/20/2005 | CN1211422C Polymer gel for oraly taken and colon released medicine and its prepn |
| 07/20/2005 | CN1211375C Thiazole-derivatives |
| 07/20/2005 | CN1211368C Amorphous torasemide modification |
| 07/20/2005 | CN1211164C Medium milling |
| 07/20/2005 | CN1211125C Olopatadine formulations for topical administration |
| 07/20/2005 | CN1211086C Sustained release ranolazine formulations |
| 07/20/2005 | CN1211085C Compositions having improved stability |
| 07/20/2005 | CN1211082C Cosmetic and pharmaceutical preparations comprising ascorbic acid derivatives |
| 07/20/2005 | CN1211079C Stable slow-releasing oral administration composition |
| 07/20/2005 | CN1211078C Regulated release preparations |
| 07/20/2005 | CN1211077C Histamine H2 antagonist effervescent composition |
| 07/20/2005 | CN1211076C Delivery systems using preformed biodegradable polymer compositions and methods |
| 07/20/2005 | CN1211070C Facial tissue compsn. and method of use for sequestration of nasal secretion skin irritants |
| 07/20/2005 | CN1211063C Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/19/2005 | US6919441 Used as inhibitors of gene expression (antisense oligonucleotides, ribozymes, sense oligonucleotides and triplex forming oligonucleotides), as probes for detecting nucleic acids and as aids in molecular biology |
| 07/19/2005 | US6919425 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 07/19/2005 | US6919424 Comprises polypeptide for, diagnosis, detection and treatment of cancer |
| 07/19/2005 | US6919378 Pharmaceutical solutions of modafinil compounds |
| 07/19/2005 | US6919372 An ionic prostanoic acid derivative, for which sustained release is required through parenteral route, and an cationic compound form a sparingly water-soluble ionic complex; increased occtanol/water partition coefficient; hydrophobic |
| 07/19/2005 | US6919370 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
| 07/19/2005 | US6919312 Polysaccharides |
| 07/19/2005 | US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 07/19/2005 | US6919091 Compositions and methods for drug delivery using pH sensitive molecules |
| 07/19/2005 | US6919088 Water-soluble stable salts of petroselinic acid |
| 07/19/2005 | US6919079 FcεPE chimeric protein for targeted treatment of allergy responses, a method for its production and pharmaceutical compositions containing the same |
| 07/19/2005 | US6919076 Conjugate of a nonextracellular matrix protein, nonlabeling agent of an anti- nerve gas, neurotoxin and gluacoma agents and a carboxamide- carrying linking molecule that contains >/= 2 linked glutamines and is a substrate of transglutaminase |
| 07/19/2005 | US6919067 Compositions comprising a tissue glue and therapeutic agents |
| 07/19/2005 | US6918929 Drug-polymer coated stent with pegylated styrenic block copolymers |
| 07/19/2005 | CA2071248C Composition containing dioxabicyclo-[3.3.0]octane derivative |
| 07/14/2005 | WO2005063819A2 Human binding molecule against cd1a |
| 07/14/2005 | WO2005063306A1 Assembly of gas-filled microvesicle with active component for contrast imaging |
| 07/14/2005 | WO2005063305A1 Gas-filled microvesicle assembly for contrast imaging |
| 07/14/2005 | WO2005063299A2 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 07/14/2005 | WO2005063298A1 Stable growth hormone liquid formulation |
| 07/14/2005 | WO2005063291A1 Stable water-based medicinal preparation containing antibody |
| 07/14/2005 | WO2005063267A1 The oral disintegratable tablet of ginkgo leaves |
| 07/14/2005 | WO2005063258A1 Kinase inhibitor phosphonate conjugates |
| 07/14/2005 | WO2005063243A1 Pharmaceutical compositions |
| 07/14/2005 | WO2005063229A1 Pregabalin composition |
| 07/14/2005 | WO2005063224A1 Topical preparations containing dimethyl sulfoxide and dexpanthenol |
| 07/14/2005 | WO2005063218A2 Pharmaceutical formulations of bisphosphonates |
| 07/14/2005 | WO2005063213A1 Rigid liposomal cochleate and methods of use and manufacture |
| 07/14/2005 | WO2005063212A1 Cholesteryl hemisuccinate incorporated lipid-based nano-carriers and skin-care compositions for external application containing the same |
| 07/14/2005 | WO2005063208A1 Consumer customized dosage forms |
| 07/14/2005 | WO2005063207A1 Nonaqueous gel preparation for external use |
| 07/14/2005 | WO2005063205A2 Injectable phosphatidylcholine preparations |
| 07/14/2005 | WO2005063195A2 Compositions comprising vitamins and/or derivatives thereof stabilised with olea europea extract and/or ionene polymers |